ADVOCATE Clinical Trial Reveals Impact of Ceramide Infused Skin Barrier

Learn the results of the ADVOCATE clinical trial, which showed the impact of a ceramide infused skin barrier on cost of care and patient satisfaction.

The ADVOCATE trial is a double-blinded, randomized, controlled study. It compares ostomy-related costs and incidence of peristomal skin complications (PSCs) for a ceramide infused ostomy skin barrier versus a control skin barrier.

This type of evidence offers credible data to help support evidence-based clinical decision making. It also demonstrates positive outcomes with the use of a ceramide infused barrier – the CeraPlus™ skin barrier with Remois Technology.* The CeraPlus™ skin barrier is carefully formulated, and infused with ceramide, to create an environment where healthy skin can thrive.

Read this article in the Journal of Wound, Ostomy, and Continence Nursing to learn about the ADVOCATE trial. You can also watch this video, in which the study authors discuss the experience of participating in the trial and give their clinical perspectives on the results.

*Remois is a technology of Alcare Co., Ltd.

Click here to find the IFU(s) for the product(s) featured in this case study.